Artios Pharma Publishes Preclinical Data on The First Selective Small Molecule Polθ Polymerase Inhibitor in Nature Communications
| Press release
News & Events
Artios Pharma Announces Collaboration with Novartis to Create Next Generation DDR Cancer Therapies
| Press release
Niall Martin, Chief Executive Officer presented a company overview at LifeSci Partners Precision Oncology Day
| Conferences
Artios Pharma Announces the Start of First Clinical Study with the Dosing of its ATR Inhibitor, ART0380, to Patients
| Press release
Artios Pharma Expands US Leadership Team with the Appointment of Abid Ansari as Chief Financial Officer
| Press release
Artios shaking up the Biotech scene in Cambridge Top 15 !
| Media coverage
